Strategies for Selective Pathogenic B Cell Depletion in Inflammatory Diseases

• Identifying disease-specific B cell populations driving autoimmune diseases
• Benefit and challenges of targeting pathogenic B cells; identification of disease relevant animal models
• Prioritising targets by balancing specificity, patient coverage, and safety to enable precision depletion while minimising off-target immune suppression

Speakers:

Christophe Quéva

Chief Scientific Officer

Triptych health